sr141716 has been researched along with jd5037 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berbaum, J; Chorvat, RJ; McElroy, JF; Seriacki, K | 1 |
| Chorvat, RJ | 1 |
| Carlson, OD; Cieśla, Ł; Cimbro, R; Doyle, ME; Egan, JM; Ghosh, S; González-Mariscal, I; Krzysik-Walker, SM; Liu, QR; Moaddel, R; O'Connell, JF; Santa-Cruz Calvo, S; Witek, RP | 1 |
| Cinar, R; Gao, B; Godlewski, G; Gunduz-Cinar, O; Herrerias, A; Iyer, MR; Kunos, G; Lin, Y; Santos-Molina, L; Wood, CM; Zawatsky, CN | 1 |
1 review(s) available for sr141716 and jd5037
| Article | Year |
|---|---|
Peripherally restricted CB1 receptor blockers.
Topics: Animals; Brain; Cocaine; Drug Discovery; Humans; Liver Diseases; Metabolic Diseases; Morpholines; Obesity; Piperidines; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Sulfonamides | 2013 |
3 other study(ies) available for sr141716 and jd5037
| Article | Year |
|---|---|
JD-5006 and JD-5037: peripherally restricted (PR) cannabinoid-1 receptor blockers related to SLV-319 (Ibipinabant) as metabolic disorder therapeutics devoid of CNS liabilities.
Topics: Amidines; Brain Diseases, Metabolic; Dose-Response Relationship, Drug; Humans; Molecular Structure; Pyrazoles; Receptor, Cannabinoid, CB1; Recombinant Proteins; Structure-Activity Relationship; Sulfonamides | 2012 |
Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism.
Topics: Amino Acid Sequence; Animals; Cells, Cultured; CHO Cells; Cricetinae; Cricetulus; Gene Expression Profiling; Glucose; Hepatocytes; Humans; Insulin; Insulin Secretion; Insulin-Secreting Cells; Metabolic Diseases; Piperidines; Protein Isoforms; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Sequence Homology, Amino Acid; Sulfonamides | 2016 |
Effects of a Peripherally Restricted Hybrid Inhibitor of CB1 Receptors and iNOS on Alcohol Drinking Behavior and Alcohol-Induced Endotoxemia.
Topics: Alcohol Drinking; Animals; Anxiety; Behavior, Animal; Cannabinoid Receptor Antagonists; Catalepsy; Cyclohexanols; Elevated Plus Maze Test; Endotoxemia; Endotoxins; Ethanol; Gastrointestinal Tract; Hypothermia, Induced; Mice, Inbred C57BL; Nitric Oxide Synthase Type II; Pyrazoles; Receptor, Cannabinoid, CB1; Rimonabant; Stereoisomerism; Sulfonamides | 2021 |